[BGLC] QoQ Quarter Result on 30-Sep-2023 [#Q3]

Stock
[BGLC] BioNexus Gene Lab Corp.
Announcement Date
31-May-2024
Financial Year
2023
Quarter
30-Sep-2023 [#Q3]
Profit Trend
QoQ- -906.95%
YoY- -3,287.01%
Quarter Report
BGLC's Result
BGLC's Financial Summary
View:
Show?
Quarter Result
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
Revenue 1,975 2,382 2,273 2,554 2,567 2,377 2,840 -21.52%
PBT 255 -84 253 -2,532 -275 -53 -127 -
Tax 56 20 -55 76 -16 16 30 51.66%
NP 199 -104 307 -2,608 -259 -69 -157 -
Tax Rate -21.82% - 21.74% - - - - -
Total Cost 1,775 2,486 1,966 5,162 2,826 2,446 2,997 -29.49%
Ratio Analysis
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
NP Margin 10.08 -4.36 13.52 -102.13 -10.10 -2.91 -5.53 -
Per Share
30/06/24 31/03/24 31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 CAGR
EPS 0.01 -0.01 0.02 -0.16 -0.02 -0.00 -0.01 -
EPS Diluted 0.01 -0.01 0.02 -0.16 -0.02 -0.00 -0.01 -

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.